Risk Factors for Acquisition of Extended-spectrum Beta-lactamase and AmpC Resistant Gram-negative Bacteria in Critically Ill Infants With Congenital Heart Disease
- Resource Type
- Authors
- Rosemary Olivero; Andrea K Borst; Sara L Ogrin; Anthony Olivero; Daliya Khuon
- Source
- Pediatric Infectious Disease Journal. 40:738-740
- Subject
- Heart Defects, Congenital
Male
Microbiology (medical)
medicine.medical_specialty
Serratia
Gram-negative bacteria
Heart disease
medicine.drug_class
Critical Illness
medicine.medical_treatment
Antibiotics
Enterobacter
MEDLINE
Intensive Care Units, Pediatric
beta-Lactam Resistance
beta-Lactamases
Cohort Studies
Citrobacter
Bacterial Proteins
Risk Factors
Klebsiella
Internal medicine
Intensive care
Escherichia coli
Prevalence
medicine
Humans
Retrospective Studies
Pediatric intensive care unit
Cross Infection
biology
business.industry
Infant
Hospitals, Pediatric
biology.organism_classification
medicine.disease
Infectious Diseases
Case-Control Studies
Pediatrics, Perinatology and Child Health
Cohort
Beta-lactamase
Female
Gram-Negative Bacterial Infections
business
- Language
- ISSN
- 0891-3668
In a cohort of 257 infants with congenital heart disease admitted to the pediatric intensive care unit, 22 infants had positive cultures for extended-spectrum beta-lactamase or AmpC Gram-negative bacteria. These infants had longer exposure to broad-spectrum antibiotics, greater support with invasive devices and longer intensive care and hospital lengths of stay.